Toll-like receptor 2 antagonists. Part 1: Preliminary SAR investigation of novel synthetic phospholipids
摘要:
Novel synthetic phospholipid compound I was discovered to be an antagonist of human toll-like receptor 2 (TLR2) signaling. In a preliminary SAR campaign we synthesized several analogues of 1 and found that considerable structural changes could be made without loss of TLR2 antagonistic activity. (c) 2005 Elsevier Ltd. All rights reserved.
Toll-like receptor 2 antagonists. Part 1: Preliminary SAR investigation of novel synthetic phospholipids
摘要:
Novel synthetic phospholipid compound I was discovered to be an antagonist of human toll-like receptor 2 (TLR2) signaling. In a preliminary SAR campaign we synthesized several analogues of 1 and found that considerable structural changes could be made without loss of TLR2 antagonistic activity. (c) 2005 Elsevier Ltd. All rights reserved.
Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
申请人:Chow Jesse
公开号:US20050113345A1
公开(公告)日:2005-05-26
The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.
本发明涉及用于预防或治疗与 Toll 样受体 2 激活有关的疾病或病症的化合物和方法。
COMPOUNDS AND METHODS FOR TREATING TOLL-LIKE RECEPTOR 2-RELATED DISEASES AND CONDITIONS
申请人:Eisai Co., Ltd.
公开号:EP1697389A2
公开(公告)日:2006-09-06
EP1697389A4
申请人:——
公开号:EP1697389A4
公开(公告)日:2008-12-24
Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions
申请人:Chow Jesse
公开号:US20070167409A1
公开(公告)日:2007-07-19
The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.